Nerve Growth Factor–Evoked Masseter Muscle Sensitization and Perturbation of Jaw Motor Function in Healthy Women

Aim: To replicate and extend previous findings of nerve growth factor (NGF)-induced mechanical sensitization in healthy young men to women and test for associations between mechanical sensitization and oral motor function. Combined these data would indicate if injection of NGF into the masseter muscle is a valid model of muscle pain related to temporomandibular disorders (TMD). Methods: A double-blind, placebo-controlled study was conducted on 14 healthy women. Each subject received an injection of NGF (5 µg in 0.2 mL) into 1 masseter muscle and buffered isotonic saline (control, 0.2 mL) into the other. Pressure pain thresholds (PPT) and pressure pain tolerance (PPTOL) as well as self-assessed pain intensity (numeric rating scale of 1 to 10) with the jaw at rest and in relation to various motor activities (chewing, yawning, talking, swallowing, drinking, and smiling) were recorded prior to and 3 hours, 1 day, 7 days, 14 days, and 21 days postinjection. ANOVAs were used to test data. Results: It was found that NGF significantly reduced PPT and PPTOL 3 hours, 1 and 7 days postinjection (P < .001). Numerical rating scale (NRS) scores during chewing and yawning were significantly increased 3 hours and 1 day following NGF injection (P < .001). After 3 hours, there were significant correlations between relative changes in PPTs and NRS scores during chewing (r = –0.556; P = .037), between relative changes in PPTOL and NRS scores during yawning (r = –0.607; P = .020), and between relative changes in PPTOL and maximum unassisted jaw-opening capacity (r = 0.868; P < .001). Conclusion: This study shows that injection of NGF into the masseter muscle of women causes local signs of mechanical allodynia and hyperalgesia that persist for at least 7 days as well as pain during strenuous jaw movement. Taking the authors’ previous results on NGF effects in men into consideration, these findings lend additional support to the suggestion that this model may serve as a proxy of some of the clinical features of TMD-related muscle pain.

allodynia; jaw motor function; nerve growth factor; pain measurement; TMD pain

1. Pezet S, McMahon SB. Neurotrophins: Mediators and modulators of pain. Annu Rev Neurosci 2006;29:507-538.

2. McMahon SB, Bennett DLH, Bevan S. Inflammatory mediators and modulators of pain. In: McMahon SB, Koltzenburg M (eds). Wall and Melzak’s Textbook of Pain, ed 5. Philadelphia: Elsevier/Churchill Livingstone, 2006:49-72.

3. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997;79:572-577.

4. Friess H, Zhu ZW, di Mola FF, et al. Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999;230:615-624.

5. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syn-drome. Urology 2002;59:603-608.

6. Saldanha G, Hongo J, Plant G, Acheson J, Levy I, Anand

P. Decreased CGRP, but preserved Trk A immunoreactiv-ity in nerve fibres in inflamed human superficial temporal arteries. J Neurol Neurosurg Psychiatry 1999;66:390-392.

7. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 2001;57:132-134.

8. Dray A, Read SJ. Arthritis and pain. Future targets to con-trol osteoarthritis pain. Arthritis Res Ther 2007;9:212.

9. Ellrich J, Makowska A. Nerve growth factor and ATP excite different neck muscle nociceptors in anaesthetized mice. Cephalalgia 2007;27:1226-1235.

10. Makowska A, Panfil C, Ellrich J. Nerve growth factor injection into semispinal neck muscle evokes sustained facilitation of the jaw-opening reflex in anesthetized mice: Possible implications for tension-type headache. Exp Neurol 2005;191:301-309.

11. Hoheisel U, Unger T, Mense S. Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 2005;114:168-176.

12. Hoheisel U, Unger T, Mense S. Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracel-lular recordings in vivo. Brain Res 2007;1169:34-43.

13. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 2003;104:241-247.

14. Dworkin SF, LeResche L (eds). Research Diagnostic Criteria for Temporomandibular Disorders: Review, crite-ria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain 1992;6:301-355.

15. Mann MK, Dong X-D, Svensson P, Cairns BE. Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers. J Orofac Pain 2006;20:325-336.

16. Karibe H, Goddard G, Gear RW. Sex differences in masti-catory muscle pain after chewing. J Dent Res 2003;82:112-116.

17. Melzack R. The McGill Pain Questionnaire: Major prop-erties and scoring methods. Pain 1975;1:277-299.

18. Petty BG, Cornblath DR, Adornato BT, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994;36:244-246.

19. Dyck PJ, Peroutka S, Rask C, et al. Intradermal recombi-nant human nerve growth factor induces pressure allody-nia and lowered heat-pain threshold in humans. Neurology 1997;48:501-505.

20. Svensson P, Arendt-Nielsen L, Nielsen H, Larsen JK. Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves. J Orofac Pain 1995;9:347-356.

21. Svensson P, Graven-Nielsen T, Arendt-Nielsen L. Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 1998;74:93-100.

22. Svensson P, Arendt-Nielsen L. Effects of 5 days of repeated submaximal clenching on masticatory muscle pain and tenderness: An experimental study. J Orofac Pain 1996;10:330-338.

23. Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: Evidence for altered temporal summation of pain. Pain 1998;76:71-81.

24. Svensson P, List T, Hector G. Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001;92:399-409.

25. Reid KI, Gracely RH, Dubner RA. The influence of time, facial side, and location on pain-pressure thresholds in chronic myogenous temporomandibular disorder. J Orofac Pain 1994;8:258-265.

26. Sarlani E, Grace EG, Reynolds MA, Greenspan JD. Evidence for up-regulated central nociceptive processing in patients with masticatory myofascial pain. J Orofac Pain 2004;18:41-55.

27. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of tem-poromandibular disorder pain. Pain 1997;69:153-160.

28. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253-261.

29. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-192.

30. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006;26:5777-5785.

31. Dong XD, Mann MK, Kumar U, et al. Sex-related differ-ences in NMDA-evoked rat masseter muscle afferent dis-charge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 2007; 146:822-832.

32. Stohler CS. Masticatory myalgias. Emphasis on the nerve growth factor-estrogen link. Pain Forum 1997;6:176-180.

33. Svensson P. Pain mechanisms in myogenous temporo-mandibular disorders. Pain Forum 1997;6:158-165.

34. Graven-Nielsen T, Segerdahl M, Svensson P, Arendt-Nielsen L. Methods for induction and assessment of pain in humans with clinical and pharmacological examples. In: Kruger L (ed). Methods in Pain Research. Boca Raton, FL: CRC Press, 2001:263-304.

35. Svensson P, Graven-Nielsen T. Craniofacial muscle pain: Review of mechanisms and clinical manifestations. J Orofac Pain 2001;15:117-145.

36. Svensson P, Cairns BE, Wang K, et al. Glutamate-induced sensitization of pressure pain thresholds in human mas-seter muscle. Pain 2003;101:221-227.

37. Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 2000;85:31-39.

38. Arima T, Svensson P, Arendt-Nielsen L. Capsaicin-induced muscle hyperalgesia in the exercised and non-exercised human masseter muscle. J Orofac Pain 2000;14:213-223.

39. Mork H, Ashina M, Bendtsen L, Olesen J, Jensen R. Experimental muscle pain and tenderness following infu-sion of endogenous substances in humans. Eur J Pain 2003;7:145-153.

40. Sohn MK, Graven-Nielsen T, Arendt-Nielsen L, Svensson P. Effects of experimental muscle pain on mechanical proper-ties of single motor units in human masseter. Clin Neurophysiol 2004;115:76-84.

41. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain perception and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001;86:782-791.

42. Cairns BE, Svensson P, Wang K, et al. Activation of periph-eral NMDA receptors contributes to human pain and rat afferent fiber discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2003;90:2098-2105.

43. Gazerani P, Wang K, Cairns BE, Svensson P, Arendt-Nielsen L. Effects of subcutaneous administration of glu-tamate on pain, sensitization and vasomotor responses in healthy men and women. Pain 2006;124:338-348.

44. Greenspan JD, Craft RM, LeResche L, et al; Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007;132:26-45.

45. Hu JW, Sessle BJ, Raboisson P, Dallel R, Woda A. Stimulation of craniofacial muscle afferents induces pro-longed facilitatory effects in trigeminal nociceptive brain-stem neurones. Pain 1992;48:53-60.

46. Watanabe M, Tanaka E, Nishi M, et al. Expression of c-Fos-like immunoreactive neurons in the supratrigeminal region in the rat following noxious stimulation of the oro-facial tissues. Neurosci Lett 2002;335:99-102.

47. Sugiyo S, Takemura M, Dubner R, Ren K. Trigeminal tran-sition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflam-mation in rats. J Comp Neurol 2005;493:510-523.

48. Dao TT, Lund JP, Lavigne GJ. Pain responses to experi-mental chewing in myofascial pain patients. J Dent Res 1994;73:1163-1167.

49. Gavish A, Winocur E, Menashe S, Halachmi M, Eli I, Gazit

E. Experimental chewing in myofascial pain patients. J Orofac Pain 2002;16:22-28.

50. Svensson P, Arendt-Nielsen L, Houe L. Sensory-motor interactions of human experimental unilateral jaw muscle pain: A quantitative analysis. Pain 1996;64:241-249.

51. Svensson P, Macaluso GM, De Laat A, Wang K. Effects of local and remote muscle pain on human jaw reflexes evoked by fast stretches at different clenching levels. Exp Brain Res 2001;139:495-502.

52. Wang K, Svensson P, Arendt-Nielsen. Effect of tonic muscle pain on short-latency jaw-stretch reflexes in humans. Pain 2000;88:189-197.